Work

371 Phase 2 randomized discontinuation trial (RDT) of XL184 in patients (pts) with advanced solid tumors

Year: 2010

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(10)72078-4

Authors: P. Schöffski, M. Sgroi, H.A. Burris, J. Lutzky, T. Rearden, B. Sikic, J. Stephenson, D. Elhardt, Y. Lee, R. Kurzrock

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2018124225

Cites:

Cited by: 3

Related to: 10